The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Renal injury from angiotensin II-mediated hypertension.
Abstract
Angiotensin II (Ang II)-mediated hypertension induces vascular smooth muscle cell hypertrophy and hyperplasia in systemic blood vessels, but the effects of Ang II on the intrinsic cell populations within the kidney have been less well characterized. We infused Ang II for 14 days into rats by minipump at doses (200 ng/min) that resulted in moderate hypertension (mean systolic blood pressure 156-172 mm Hg). Small renal arterial vessels of Ang II-infused rats demonstrated focal injury with fibrinoid necrosis and medial hyperplasia, whereas the glomerular capillaries demonstrated only rare segmental hyalinosis. Proliferation of vascular smooth muscle cells was pronounced (fourfold to 20-fold increase in [3H]thymidine incorporation) as opposed to a minimal proliferation of glomerular cells in Ang II-infused rats. In contrast, the principal effect of Ang II in glomeruli was to increase the expression of alpha-smooth muscle actin by mesangial cells and desmin by visceral glomerular epithelial cells. Ang II-infused rats also developed focal tubulointerstitial injury, with tubular atrophy and dilation, cast formation, an interstitial monocytic infiltrate, and mild interstitial fibrosis with increased type IV collagen deposition. The injury was associated with a proliferation of distal tubule, collecting duct, and interstitial cells as determined by immunostaining for proliferating cell nuclear antigen, and was accompanied by an increase in platelet-derived growth factor B-chain messenger RNA in the area of interstitial injury as localized by in situ hybridization. Renal interstitial cells also underwent phenotypic modulation in which they expressed alpha-smooth muscle actin. Vehicle-infused control rats displayed no tubular injury, proliferation, or phenotypic modulation. Thus, Ang II in doses that cause moderate hypertension induces marked vascular, glomerular, and tubulointerstitial injury with cell proliferation, leukocyte recruitment, phenotypic modulation with the upregulation of proteins normally associated with smooth muscle cells, and interstitial fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiological aspects of primary hypertension.
Folkow, B. (1982) · Physiological Reviews · doi:10.1152/physrev.1982.62.2.347 · Cited by 1,768
Skalli, O., Ropraz, P., Trzeciak, A., Benzonana, G., Gillessen, D., & Gabbiani, G. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.6.2787 · Cited by 1,621
Dijkstra, C. D., Döpp, E. A., Joling, P., & Kraal, G. (1985) · Microenvironments in the Lymphoid System · doi:10.1007/978-1-4613-2463-8_50 · Cited by 1,598
Darby, I. A., Skalli, O., & Gabbiani, G. (1990) · PubMed · Cited by 1,189
Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.
Geisterfer, A. A., Peach, M. J., & Owens, G. K. (1988) · Circulation Research · doi:10.1161/01.res.62.4.749 · Cited by 1,065
Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury
Powell, J. S., Clozel, J.-P., Müller, R. K. M., Kuhn, H., Hefti, F., Hosang, M., & Baumgartner, H. R. (1989) · Science · doi:10.1126/science.2526370 · Cited by 1,052
Replication of smooth muscle cells in vascular disease.
Schwartz, S. M., Campbell, G. R., & Campbell, J. H. (1986) · Circulation Research · doi:10.1161/01.res.58.4.427 · Cited by 759
Self-citationAngiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.
Daemen, M. J., Lombardi, D. M., Bosman, F. T., & Schwartz, S. M. (1991) · Circulation Research · doi:10.1161/01.res.68.2.450 · Cited by 737
Self-citationNaftilan, A. J., Pratt, R. E., & Dzau, V. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114032 · Cited by 623
Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle
Kurki, P., Vanderlaan, M., Dolbeare, F., Gray, J., & Tan, E. M. (1986) · Experimental Cell Research · doi:10.1016/0014-4827(86)90520-3 · Cited by 519
Cited by
Cell biology of the glomerular podocyte
Pavenstädt, H., Kriz, W., & Kretzler, M. (2003) · Physiological Reviews · doi:10.1152/physrev.00020.2002 · Cited by 1,499
Pathophysiology of Progressive Nephropathies
Remuzzi, G., & Bertani, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811123392007 · Cited by 1,269
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Gilbert, R. E., & Cooper, M. E. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00721.x · Cited by 649
Molecular insights into renal interstitial fibrosis.
Eddy, A. A. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7122495 · Cited by 637
Basile, D. P., Donohoe, D., Roethe, K., & Osborn, J. L. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.5.f887 · Cited by 619
Aldosterone-Induced Inflammation in the Rat Heart
Sun, Y., Zhang, J., Lu, L., Chen, S. S., Quinn, M. T., & Weber, K. T. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64454-9 · Cited by 567
Extracellular Matrix Remodeling in Heart Failure: A Role for De Novo Angiotensin II Generation
Weber, K. T. (1997) · Circulation · doi:10.1161/01.cir.96.11.4065 · Cited by 557
Angiotensin II and Renal Fibrosis
Mezzano, S. A., Ruiz-Ortega, M., & Egido, J. (2001) · Hypertension · doi:10.1161/hy09t1.094234 · Cited by 523
Subtle Acquired Renal Injury as a Mechanism of Salt-Sensitive Hypertension
Johnson, R. J., Herrera-Acosta, J., Schreiner, G. F., & Rodríguez-Iturbe, B. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011078 · Cited by 448
Self-citationChronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
Bennett, W. M., DeMattos, A., Meyer, M. M., Andoh, T., & Barry, J. M. (1996) · Kidney International · doi:10.1038/ki.1996.415 · Cited by 436
Masuzaki, H., Yamamoto, H., Kenyon, C. J., Elmquist, J. K., Morton, N. M., Paterson, J. M., Shinyama, H., Sharp, M. G. F., Fleming, S., Mullins, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17845 · Cited by 434
Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases
Barnes, J. L., & Gorin, Y. (2011) · Kidney International · doi:10.1038/ki.2010.516 · Cited by 432
Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney
Ruiz-Ortega, M., Ruperez, M., Lorenzo, O., Esteban, V., Blanco, J., Mezzano, S., & Egido, J. (2002) · Kidney International · doi:10.1046/j.1523-1755.62.s82.4.x · Cited by 425
Proinflammatory actions of angiotensins
Ruiz-Ortega, M., Lorenzo, O., Suzuki, Y., Rupérez, M., & Egido, J. (2001) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200105000-00005 · Cited by 412
Ishani, A., Nelson, D., Clothier, B., Schult, T., Nugent, S., Greer, N., Slinin, Y., & Ensrud, K. E. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.514 · Cited by 406
Basile, D. P., Donohoe, D., Roethe, K., & Osborn, J. L. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00050.2001 · Cited by 404
Wolf, G., Mueller, E., Stahl, R. A., & Ziyadeh, F. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116710 · Cited by 379
Sánchez-Lozada, L. G., Tapia, E., Jiménez, A., Bautista, P., Cristóbal, M., Nepomuceno, T., Soto, V., Ávila-Casado, C., Nakagawa, T., Johnson, R. J., et al. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00124.2006 · Cited by 359
Self-citationInflammation in Renal Diseases: New and Old Players
Andrade-Oliveira, V., Foresto-Neto, O., Watanabe, I. K. M., Zatz, R., & Câmara, N. O. S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01192 · Cited by 330
Cellular events in the evolution of experimental diabetic nephropathy
Young, B. A., Johnson, R. J., Alpers, C. E., Eng, E., Gordon, K., Floege, J., Couser, W. G., & Seidel, W. T. S. A. F. S. K. (1995) · Kidney International · doi:10.1038/ki.1995.139 · Cited by 318
Self-citationA New Look at Platelet-Derived Growth Factor in Renal Disease
Floege, J. D., Eitner, F., & Alpers, C. E. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050532 · Cited by 302
Self-citationMechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats
Kliem, V., Johnson, R. J., Alpers, C. E., Yoshimura, A., Couser, W. G., Koch, K. M., & Floege, J. (1996) · Kidney International · doi:10.1038/ki.1996.95 · Cited by 281
Self-citationLoss of Angiotensin-Converting Enzyme-2 (Ace2) Accelerates Diabetic Kidney Injury
Wong, D. W., Oudit, G. Y., Reich, H., Kassiri, Z., Zhou, J., Liu, Q. C., Backx, P. H., Penninger, J. M., Herzenberg, A. M., & Scholey, J. W. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060977 · Cited by 273
Angiotensin II induces superoxide anion production by mesangial cells
Jaimes, E. A., Galceran, J. M., & Raij, L. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00068.x · Cited by 272
Cheng, S., & Lovett, D. H. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64327-1 · Cited by 258
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin.
Pichler, R. H., Franceschini, N., Young, B. A., Hugo, C., Andoh, T. F., Burdmann, E. A., Shankland, S. J., Alpers, C. E., Bennett, W. M., & Couser, W. G. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v641186 · Cited by 256
Self-citationAldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo
Brown, N. J., Nakamura, S., Ma, L., Nakamura, I., Donnert, E., Freeman, M., Vaughan, D. E., & Fogo, A. B. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00277.x · Cited by 255
Wolf, G., Ziyadeh, F. N., Thaiss, F., Tomaszewski, J., Caron, R. J., Wenzel, U., Zahner, G., Helmchen, U., & Stahl, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119615 · Cited by 253
Hu, J., Luo, H., Wang, J., Tang, W., Lu, J., Wu, S., Xiong, Z., Yang, G., Chen, Z., Lan, T., et al. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.122 · Cited by 126
Inflammation in hypertension: primary evidence
LI, J.-J. (2006) · Chinese Medical Journal · doi:10.1097/00029330-200607020-00016 · Cited by 32
Metadata
- Authors
- Johnson, R. J., Alpers, C. E., Yoshimura, A., Lombardi, D., Pritzl, P., Floege, J., & Schwartz, S. M.
- Venue
- Hypertension
- Published
- 1992-05
- Volume
- 19
- Issue
- 5
- Pages
- 464-474
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2149482537
- Cited by
- 536
- References
- 34
- FWCI
- 16.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.